T cell alterations and lymphoid neogenesis favoring autoimmunity in Wegener's granulomatosis

Arthritis and Rheumatism

Volumn 56, Issue 6, 2007, Pages 1725-1727

  Lamprecht, Peter ^a,b   Gross, Wolfgang L ^a,b   Kabelitz, Dieter ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Rheumaklinik Bad Bramstedt   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; EDITORIAL; GLOMERULONEPHRITIS; HUMAN; INFLAMMATION; LYMPHANGIOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; VASCULITIS; WEGENER GRANULOMATOSIS; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGENS, CD4; AUTOIMMUNITY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOID TISSUE; T-LYMPHOCYTES, REGULATORY; WEGENER GRANULOMATOSIS;

EID: 34447500353     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22693     Document Type: Editorial

References (17)

1. Jayne DR, Rasmussen N. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 1997;72:737-47.
2. Bacon PA. The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med 2005;352:330-2.
3. Lu X, Garfield A, Rainger GE, Savage CO, Nash GB. Mediation of endothelial cell damage by serine proteases, but not superoxide, released from antineutrophil cytoplasmic antibody-stimulated neutrophils. Arthritis Rheum 2006;54:1619-28.
4. Davis LS, Schulze-Koops H, Lipsky PE. Human CD4+ T cell differentiation and effector function: implications for autoimmunity. Immunol Res 1999;19:25-34.
5. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T-cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
6. Viret C, Janeway CA. MHC and T cell development. Rev Immunogenet 1999;1:91-104.
7. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-22.
8. + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971-9.
9. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004;200:277-85.
10. Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007;56:2079-90.
11. Wang J, Ioan Facsinay A, van der Voort EI, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007;37:129-38.
12. Pasare C, Medzhitov R. Toll-pathway dependent blockade of CD4+CD25+ T-cell mediated suppression by dendritic cells. Science 2003;299:1033-6.
13. Kabelitz D, Wesch D, Oberg HH. Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit Rev Immunol 2006;26:291-306.
14. Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, et al. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006;107:4440-8.
15. - T-cells are a major source of IFN-γ and TNF-α in Wegener's granulomatosis. Am J Pathol 2002;160:1717-24.
16. Voswinkel J, Mueller A, Kraemer JA, Lamprecht P, Herlyn K, Holl-Ulrich K, et al. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006;65:859-64.
17. Zinkernagel RM. Antiinfection immunity and autoimmunity. Ann N Y Acad Sci 2002;958:3-6.